Overview

Gene Location [1]
19p13.2
Variant Type
Loss
Gene
SMARCA4

SMARCA4 Loss is present in 0.10% of AACR GENIE cases, with lung adenocarcinoma, breast invasive ductal carcinoma, cancer of unknown primary, high grade ovarian serous adenocarcinoma, and adenocarcinoma of unknown primary having the greatest prevalence [4].

Top Disease Cases with SMARCA4 Loss

Significance of SMARCA4 Loss in Diseases

Medulloblastoma +

Malignant Solid Tumor +

Medulloblastoma, Non-WNT/Non-SHH +

Medulloblastoma, WNT-Activated +

Rhabdoid Tumor +

Non-Hodgkin Lymphoma +

Lymphoma +

Breast Carcinoma +

Bladder Carcinoma +

Anaplastic Astrocytoma +

Atypical Teratoid/Rhabdoid Tumor +

Central Nervous System Embryonal Neoplasm +

Central Nervous System Ganglioneuroblastoma +

Central Nervous System Neuroblastoma +

Desmoplastic/Nodular Medulloblastoma +

Endometrial Endometrioid Adenocarcinoma +

Epithelioid Sarcoma +

Glioblastoma +

Large Cell/Anaplastic Medulloblastoma +

Medulloblastoma With Extensive Nodularity +

Medulloblastoma, SHH-Activated +

Medulloepithelioma +

Synovial Sarcoma +

Non-Small Cell Lung Carcinoma +

Esophageal Adenocarcinoma +

Ovarian Carcinoma +

Gastric Adenocarcinoma +

Soft Tissue Sarcoma +

Acute Myeloid Leukemia +

Pancreatic Carcinoma +

Sarcoma +

Colorectal Carcinoma +

Acute Biphenotypic Leukemia +

Acute Leukemia Of Ambiguous Lineage +

Acute Lymphoblastic Leukemia +

Adenocarcinoma Of The Gastroesophageal Junction +

Anaplastic Astrocytoma, IDH-Mutant +

Anaplastic Ependymoma +

Anaplastic Oligodendroglioma +

Anaplastic Oligodendroglioma, IDH-Mutant And 1p/19q-Codeleted +

Anaplastic Pleomorphic Xanthoastrocytoma +

Diffuse Glioma +

Diffuse Midline Glioma, H3 K27M-Mutant +

Embryonal Tumor With Multilayered Rosettes, C19MC-Altered +

Embryonal Tumor With Multilayered Rosettes, Not Otherwise Specified +

Ependymoma +

Ependymoma, RELA Fusion-Positive +

Esophageal Squamous Cell Carcinoma +

Extrarenal Rhabdoid Tumor +

Gastric Squamous Cell Carcinoma +

Head And Neck Carcinoma +

Hepatoblastoma +

High-Grade Glioma, NOS +

Histiocytic And Dendritic Cell Neoplasm +

Intracranial Primitive Neuroectodermal Neoplasm +

Malignant Central Nervous System Neoplasm +

Malignant Glioma +

Malignant Ovarian Clear Cell Tumor +

Malignant Ovarian Endometrioid Tumor +

Melanoma +

Mixed Phenotype Acute Leukemia +

Ovarian Clear Cell Adenocarcinoma +

Ovarian Endometrioid Adenocarcinoma +

Ovarian Small Cell Carcinoma, Hypercalcemic Type +

Pineoblastoma +

Retinoblastoma +

Rhabdoid Tumor Of The Kidney +

Sarcomatoid Carcinoma +

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.

Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.

4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

5. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.